Literature DB >> 10408805

The immunobiology of multiple sclerosis: an autoimmune disease of the central nervous system.

P Conlon1, J R Oksenberg, J Zhang, L Steinman.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10408805     DOI： 10.1006/nbdi.1999.0239

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN： 0969-9961            Impact factor:   5.996


× No keyword cloud information.
  17 in total

1.  Gene-expression profiling of experimental autoimmune encephalomyelitis.

Authors:  Eilhard Mix; Jens Pahnke; Saleh M Ibrahim
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

2.  Effects of particulate matter exposure on multiple sclerosis hospital admission in Lombardy region, Italy.

Authors:  Laura Angelici; Mirko Piola; Tommaso Cavalleri; Giorgia Randi; Francesca Cortini; Roberto Bergamaschi; Andrea A Baccarelli; Pier Alberto Bertazzi; Angela Cecilia Pesatori; Valentina Bollati
Journal:  Environ Res       Date:  2015-12-06       Impact factor: 6.498

3.  Integrin targeted therapeutics.

Authors:  Melissa Millard; Srinivas Odde; Nouri Neamati
Journal:  Theranostics       Date:  2011-02-17       Impact factor: 11.556

4.  Targeting macrophages by an aza-anthrapyrazole to ameliorate experimental autoimmune encephalomyelitis.

Authors:  Boren Lin; Dylan Launder; Destiny Y Bailey; Frank K Assifuah; Olivia A Miller; Heather R Conti; Jianyang Du; Boyd M Koffman
Journal:  Mult Scler Relat Disord       Date:  2020-05-16       Impact factor: 4.339

Review 5.  Gene therapy in experimental autoimmune encephalomyelitis.

Authors:  P M Mathisen; V K Tuohy
Journal:  J Clin Immunol       Date:  2000-09       Impact factor: 8.317

Review 6.  Interferon-beta therapy in multiple sclerosis: evidence for a clinically relevant dose response.

Authors:  D S Goodin
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 7.  Sterols and oxysterols in immune cell function.

Authors:  Nathanael J Spann; Christopher K Glass
Journal:  Nat Immunol       Date:  2013-09       Impact factor: 25.606

Review 8.  The therapeutic potential of HDAC inhibitors in the treatment of multiple sclerosis.

Authors:  Giuseppe Faraco; Leonardo Cavone; Alberto Chiarugi
Journal:  Mol Med       Date:  2011-02-25       Impact factor: 6.354

Review 9.  HIV in the CNS: pathogenic relationships to systemic HIV disease and other CNS diseases.

Authors:  D M Rausch; M R Davis
Journal:  J Neurovirol       Date:  2001-04       Impact factor: 2.643

10.  Early stage and long term treatment of multiple sclerosis with interferon-beta.

Authors:  Angela Applebee; Hillel Panitch
Journal:  Biologics       Date:  2009-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.